KRAS and cancer: However, most prior investigations have primarily focused on the canonical role of SHOC2 in regulation of the RAS-MAPK signal, particularly in cancer cells carrying K-Ras, N-Ras, and B-Raf oncogenic mutations or in KrasG12D-induced mice tumor models.